Hollencrest Capital Management’s Zimmer Biomet ZBH Stock Holding History

Hollencrest Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.3K	Hold	50	–	–	﹤0.01%	937
2026 Q1	$4.52K	Hold	50	–	–	﹤0.01%	937
2025 Q4	$4.5K	Hold	50	–	–	﹤0.01%	925
2025 Q3	$4.92K	Hold	50	–	–	﹤0.01%	901
2025 Q2	$4.56K	Hold	50	–	–	﹤0.01%	881
2025 Q1	$5.66K	Sell	50 -1	-2%	-$107	﹤0.01%	859
2024 Q4	$5.39K	Hold	51	–	–	﹤0.01%	884
2024 Q3	$5.5K	Buy	51 +1	+2%	+$109	﹤0.01%	844
2024 Q2	$5.43K	Hold	50	–	–	﹤0.01%	826
2024 Q1	$6.6K	Hold	50	–	–	﹤0.01%	768
2023 Q4	$6.08K	Hold	50	–	–	﹤0.01%	785
2023 Q3	$5.61K	Hold	50	–	–	﹤0.01%	795
2023 Q2	$7.28K	Hold	50	–	–	﹤0.01%	799
2023 Q1	$6.46K	Hold	50	–	–	﹤0.01%	809
2022 Q4	$6.38K	Buy	+50	New	+$5.8K	﹤0.01%	788

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hollencrest Capital Management's ZBH Position: Q2 2026 in Review

Hollencrest Capital Management held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 50 shares worth $4.3K. The position accounts for ﹤0.01% of the portfolio, ranked #937.

Hollencrest Capital Management first reported a position in ZBH in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.28K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Hollencrest Capital Management held 50 shares of Zimmer Biomet worth $4.3K as of Q2 2026.
Hollencrest Capital Management left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #937 holding.
Hollencrest Capital Management first reported a position in Zimmer Biomet in Q4 2022 and has held it in 15 quarters since.
Hollencrest Capital Management's Zimmer Biomet position peaked at $7.28K in Q2 2023.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.